Related references
Note: Only part of the references are listed.Rescuing Mutant CFTR: A Multi-task Approach to a Better Outcome in Treating Cystic Fibrosis
Margarida D. Amaral et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Mechanism-based corrector combination restores ΔF508-CFTR folding and function
Tsukasa Okiyoneda et al.
NATURE CHEMICAL BIOLOGY (2013)
Novel pharmacological strategies to treat cystic fibrosis
John W. Hanrahan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Future Directions in Early Cystic Fibrosis Lung Disease Research An NHLBI Workshop Report
Bonnie W. Ramsey et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner
Paul D. W. Eckford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Structure-Activity Relationships of Cyanoquinolines with Corrector-Potentiator Activity in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator Protein
John M. Knapp et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia
Guido Veit et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
Pharmacological Rescue of the Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Detected by Use of a Novel Fluorescence Platform
John P. Holleran et al.
MOLECULAR MEDICINE (2012)
Mechanisms of CFTR folding at the endoplasmic reticulum
Soo Jung Kim et al.
FRONTIERS IN PHARMACOLOGY (2012)
Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling
Elvira Sondo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function
Anna Tamanini et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Identification of a NBD1-Binding Pharmacological Chaperone that Corrects the Trafficking Defect of F508del-CFTR
Heidi M. Sampson et al.
CHEMISTRY & BIOLOGY (2011)
Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations
Nicoletta Pedemonte et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Probing Conformational Rescue Induced by a Chemical Corrector of F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutant
Wilson Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cyanoquinolines with Independent Corrector and Potentiator Activities Restore ΔPhe508-Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Function in Cystic Fibrosis
Puay-Wah Phuan et al.
MOLECULAR PHARMACOLOGY (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Emergent Properties of Proteostasis in Managing Cystic Fibrosis
William E. Balch et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Stimulation of wild-type, F508del-and G551D-CFTR chloride channels by non-toxic modified pyrrolo[2,3-b]pyrazine derivatives
Luc Dannhoffer et al.
FRONTIERS IN PHARMACOLOGY (2011)
Influence of cell background on pharmacological rescue of mutant CFTR
Nicoletta Pedemonte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures
Deborah M. Cholon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Functional Stability of Rescued ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator in Airway Epithelial Cells
Asta Jurkuvenaite et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening
Ori Kalid et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Structure and Dynamics of NBD1 from CFTR Characterized Using Crystallography and Hydrogen/Deuterium Exchange Mass Spectrometry
H. A. Lewis et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Na+/H+ Exchanger Regulatory Factor 1 Overexpression-dependent Increase of Cytoskeleton Organization Is Fundamental in the Rescue of F508del Cystic Fibrosis Transmembrane Conductance Regulator in Human Airway CFBE41o-Cells
Maria Favia et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Strict coupling between CFTR's catalytic cycle and gating of its Cl- ion pore revealed by distributions of open channel burst durations
Laszlo Csanady et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
ΔF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers
S. M. Rowe et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
Tsukasa Okiyoneda et al.
SCIENCE (2010)
Gating of the CFTR Cl- channel by ATP-driven nucleotide-binding domain dimerisation
Tzyh-Chang Hwang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Chloride channels as drug targets
Alan S. Verkman et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium
Liqun Zhang et al.
PLOS BIOLOGY (2009)
CFTR function and prospects for therapy
John R. Riordan
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Correctors promote folding of the CFTR in the endoplasmic reticulum
Tip W. Loo et al.
BIOCHEMICAL JOURNAL (2008)
Enhanced cell-surface stability of rescued ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) by pharmacological chaperones
Karoly Varga et al.
BIOCHEMICAL JOURNAL (2008)
Chemical and biological approaches synergize to ameliorate protein-folding diseases
Ting-Wei Mu et al.
CELL (2008)
Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect
Renaud Robert et al.
MOLECULAR PHARMACOLOGY (2008)
Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein
Ying Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Correctors of protein trafficking defects identified by a novel high-throughput screening assay
Graeme W. Carlile et al.
CHEMBIOCHEM (2007)
Cystic fibrosis: a disease of vulnerability to airway surface dehydration
Richard C. Boucher
TRENDS IN MOLECULAR MEDICINE (2007)
Air-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies
Hongxia Lin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Evidence for airway surface dehydration as the initiating event in CF airway disease
R. C. Boucher
JOURNAL OF INTERNAL MEDICINE (2007)
Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-β-nitrostyrene, a novel tyrosine kinase inhibitor
Wei-Ya Wang et al.
MOLECULAR PHARMACOLOGY (2006)
Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
F Van Goor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Mutations in the amino terminus of the cystic fibrosis transmembrane conductance regulator enhance endocytosis
A Jurkuvenaite et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel
ZW Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
CFTR chloride channel drug discovery - Inhibitors as antidiarrheals and activators for therapy of cystic fibrosis
A. S. Verkman et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Na+/H+ exchanger regulatory factor isoform 1 overexpression modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and activity in human airway 16HBE14o-cells and rescues ΔF508 CFTR functional expression in cystic fibrosis cells
L Guerra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Failure of cAMP agonists to activate rescued ΔF508 CFTR in CFBE41o- airway epithelial monolayers
Z Bebok et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners
CY Li et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening
N Pedemonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains
P Vergani et al.
NATURE (2005)
Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain
AL Berger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The F508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR
K Du et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes
M Sharma et al.
JOURNAL OF CELL BIOLOGY (2004)
Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker
A Taddei et al.
FEBS LETTERS (2004)
Organic solutes rescue the functional defect in ΔF508 cystic fibrosis transmembrane conductance regulator
XM Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel hERG
E Ficker et al.
CIRCULATION RESEARCH (2003)
Development of cystic fibrosis and noncystic fibrosis airway cell lines
J Zabner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Conformational and temperature-sensitive stability defects of the ΔF508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments
M Sharma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The Delta F508 mutation shortens the biochemical half-life of plasma membrane CFTR in polarized epithelial cells
GD Heda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
Share Paper
